Muser E, Benson C, Chirila C, Graham J, Woodruff K. Resource use and cost in a randomized, non-inferiority trial of paliperidone palmitate 3 versus 1-month formulations in patients with schizophrenia. Poster presented at the 2016 American Psychiatric Association Annual Meeting; May 14, 2016. Atlanta, GA.
Benson C, Chirila C, Graham J, Radder C, Zheng Q, Muser E, Woodruff K. Health resource use and cost analysis of schizophrenia patients participating in a randomized, multicenter, double-blind, relapse prevention study of paliperidone palmitate 3-month formulation. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.